Communications
cyclization.[14] Aldehyde 19 was primed for this reaction
Completion of the total synthesis of the chartellines and
related alkaloids will be reported shortly.[19]
through saponification with LiOH and coupling with amine
20[15] in the presence of BOPCl to furnish phosphonate 21 in
86% yield. Macrocyclization under the conditions developed
by Masamune, Roush, and co-workers[16] produced macro-
cycle 22 in 75% yield and set the stage for the critical
rearrangement.
Macrocycle 22 was converted into the chartelline skeleton
10 in 88% yield and in a single operation by simple
thermolytic removal of the Boc protecting group in 22
(1808C, no solvent)[17] followed by treatment of the resulting
free indole (11, Scheme 1) with NBS and aqueous KHCO3.
The structure of this crystalline substance (m.p. 190–2208C
(decomp; CH3CN)) was verified by X-ray crystallographic
analysis (see Scheme 3 for the ORTEP representation).
Although we speculate that the reaction proceeds through
intermediate 23, several degenerate pathways to 10 could also
be envisaged.
As alluded to above, a number of unanticipated road-
blocks were encountered during our efforts to accomplish
macrocyclization. Some of these experiences are briefly
summarized in Scheme 4, with the resistance of 24 to undergo
ring-closing metathesis, the failure of a seemingly simple
macrolactamization (25), and the refusal of 26 to take part in a
Heck-type[18] ring closure.
Received: February 11, 2005
Published online: May 18, 2005
Keywords: cascade reactions · chartellines · natural products ·
.
securamines · total synthesis
[1] Marine natural products have
a proven track record for
improving human health; for a review of those that are in
current medical use, see: D. J. Newman, G. M. Cragg, Curr. Med.
Chem. 2004, 11, 1693 – 1713; for some early pioneering efforts in
this field, see: W. Fenical, Chem. Rev. 1993, 93, 1673 – 1683.
[2] a) L. Chevolot, A.-M. Chevolot, M. Gajhede, C. Larsen, U.
Anthoni, C. Christophersen, J. Am. Chem. Soc. 1985, 107, 4542 –
4543; b) U. Anthoni, L. Chevolot, C. Larsen, P. H. Nielsen, C.
Christophersen, J. Org. Chem. 1987, 52, 4709 – 4712; c) U.
Anthoni, K. Bock, L. Chevolot, C. Larsen, P. H. Nielsen, C.
Christophersen, J. Org. Chem. 1987, 52, 5638 – 5639; d) L.
Rahbaek, U. Anthoni, C. Christophersen, P. H. Nielsen, B. O.
Petersen, J. Org. Chem. 1996, 61, 887 – 889; e) L. Rahback, C.
Christophersen, J. Nat. Prod. 1997, 60, 175 – 177.
[3] a) X. Lin, S. M. Weinreb, Tetrahedron Lett. 2001, 42, 2631 – 2633;
b) S. C. Chaffee, PhD Thesis, Yale University, 2001; c) X. Lin,
PhD Thesis, Pennsylvania State University, 2002; d) J. L. Pinder,
S. M. Weinreb, Tetrahedron Lett. 2003, 44, 4141 – 4143; e) P.
Korakas, PhD Thesis, Yale University, 2003; f) T. Nishikawa, S.
Kajii, M. Isobe, Chem. Lett. 2004, 33, 440 – 441; g) P. Korakas, S.
Chaffee, J. B. Shotwell, P. Duque, J. L. Wood, Proc. Natl. Acad.
Sci. USA 2004, 101, 12054 – 12057; h) T. Nishikawa, S. Kajii, M.
Isobe, Synlett 2004, 2025 – 2027.
[4] See Ref. [3] and J. A. Joule, K. Mills, Heterocyclic Chemistry,
Blackwell, Oxford, 2000, p. 589; R. J. Sundberg, Indoles, Aca-
demic Press, San Diego, 1996, p. 175.
[5] For example, see: H. Wang, A. J. Ganesan, J. Org. Chem. 2000,
65, 4685 – 4693; ring contractions of six-membered rings to form
indolenines are also known, see: P. L. Feldman, H. Rapoport, J.
Am. Chem. Soc. 1987, 109, 1603 – 1604; M. Node, H. Nagasawa,
K. Fuji, J. Org. Chem. 1990, 55, 517 – 521.
[6] a) S. Grivas, E. Ronne, Acta Chem. Scand. 1995, 49, 225 – 229;
b) J. G. Schantl, I. M. Lagoja, Heterocycles 1998, 48, 929 – 938.
[7] Y. Hayashi, S. Orikasa, K. Tanaka, K. Kanoh, Y. Kiso, J. Org.
Chem. 2000, 65, 8402 – 8405.
[8] K. Kanoh, S. Kohno, J. Katada, J. Takahashi, I. Uno, Y. Hayashi,
Bioorg. Med. Chem. Lett. 1999, 7, 1451 – 1457; E. A. Coula-
douros, A. D. Magkos, personal communication.
[9] S. Mꢀller, B. Liepold, G. J. Roth, H. J. Bestmann, Synlett 1996,
521 – 522; S. Ohira, Synth. Commun. 1989, 19, 561 – 564.
[10] Prepared from methyl-3-indoleacetate by bromination with NBS
followed by protection with a Boc group using Boc2O and
catalytic dimethylaminopyridine.
[11] K. Sonogashira, Y. Tohda, N. Hagihara, Tetrahedron Lett. 1975,
4467 – 4470.
[12] H. A. Dieck, R. F. Heck, J. Organomet. Chem. 1975, 93, 259 –
263.
[13] S. Shinjiro, K. Matsumoto, H. Tokuyama, T. Fukuyama, Org.
Lett. 2003, 5, 1891 – 1893.
[14] K. C. Nicolaou, M. W. Hꢁrter, J. L. Gunzner, A. Nadin, Liebigs
Ann. 1997, 1283 – 1301.
[15] U. Schmidt, A. Lieberknecht, J. Wild, Synthesis 1984, 53 – 60; see
also: B. M. Schiavi, D. J. Richard, M. M. Joulliꢂ, J. Org. Chem.
2002, 67, 620 – 624.
Scheme 4. Selected dead-end routes to the chartelline, securamine,
and securine carbocyclic skeletons.
Notable aspects of the approach described herein include
synthetic efficacy (approximately 19% overall yield and 10
steps); rapid access to the carbocyclic skeletons of the
chartelline, securine, and securamine alkaloids; and a remark-
able ring contraction (22!10) that proceeds in high yield,
despite the inherent ring strain of the b-lactam unit and an
abundance of discouraging literature precedent (Scheme 2).
The distinctive architecture of the chartelline alkaloids
inspired this approach, and it is possible that a similar
strategy is employed in nature to forge the intriguing spiro-b-
lactam ring in the chartellines from securine-like structures.
3716
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2005, 44, 3714 –3717